![[feed]](/style/images/feed-icon-14x14.png){kind=icon}
Grössmann, N. and Rothschedl, E. and Wolf, S. (2018): Horizon Scanning in Oncology 36th Prioritisation – 3rd quarter 2018. HSO: 36th Prioritisation.
Preview |
PDF
- Sie müssen einen PDF-Viewer auf Ihrem PC installiert haben wie z. B. GSview, Xpdf oder Adobe Acrobat Reader
553kB |
Abstract
For the 36th prioritisation (May 2018), 12 drugs were filtered out of 404 identified and were sent to prioritisation. Of these, 7 drugs were ranked as 'highly relevant' by the expert panel, 5 as 'relevant' and none as 'not relevant'. For 'highly relevant' drugs, further information including, for example, abstracts of phase III studies and licensing status is contained in this document.
| Item Type: | DSD: Horizon Scanning in Oncology |
|---|---|
| Subjects: | WB Practice of medicine > WB 300-962 Therapeutics QZ Pathology > QZ 200-380 Neoplasms.Cysts QV Pharmacology, toxicology, pharmacy > QV 60-370 Pharmacology |
| Language: | English |
| Series Name: | HSO: 36th Prioritisation |
| Deposited on: | 12 Jun 2018 10:34 |
| Last Modified: | 15 Jul 2020 17:57 |
Repository Staff Only: item control page